REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioinfra Life Science Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Bioinfra Life Science Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company mainly engaged in the research and development and manufacture of protein chip contents. The Company provides diagnostic testing services and research services. The Company provides services such as multi-biomarker blood tests, diagnosis kit development, biomarker discovery, and peptide chip development. The Company was founded on January 30, 2001 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on July 22, 2020.

Headquarters
7F, Sgi Bldg., 49 Daehak-Ro, Jongno-Gu
Seoul; Seoul;

Contact Details: Purchase the Bioinfra Life Science Inc. report to view the information.

Website: http://bioinfra.co.kr

Basic Information
Total Employees:
Purchase the Bioinfra Life Science Inc. report to view the information.
Outstanding Shares:
Purchase the Bioinfra Life Science Inc. report to view the information.
Financial Auditors:
Purchase the Bioinfra Life Science Inc. report to view the information.
Incorporation Date:
2001
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)바이오인프라생명과학
Company Performance
Financial values in the chart are available after Bioinfra Life Science Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-12.77%
Total operating revenue
-20.4%
Operating profit (EBIT)
-3.9%
EBITDA
-26.69%
Net Profit (Loss) for the Period
-68.56%
Total assets
-47.03%
Total equity
N/A
Operating Profit Margin (ROS)
-26.43%
Net Profit Margin
-90.94%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.77%
Cash Ratio
-0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?